What the business is, and whether it's a good one at a fair price.
Operates a network of hospitals across India providing in-patient and out-patient services across multiple specialties including oncology, with FY26 network revenue of INR 10,538 crore (+16% YoY) and network EBITDA margin of 26.2%; the FY26 BRSR filing separately reports turnover of Rs 8,373 crore with healthcare services contributing 98.23% of revenue. Network occupancy ran above 75% with ARPOB at INR 77,900. Digital channels contributed 31% of revenue (INR 838 crore) and international patient revenue was INR 227 crore (+12% YoY), forming 9% of hospital revenue. The largest identifiable cost line is employee costs at 16.2% of revenue, with other opex at 35.6%, depreciation at 5.3% and capex at 17.7% of revenue. Capacity is being expanded: more than 20% additional brownfield beds are being commissioned in phases, a 500-bed Gurgaon greenfield is targeted for end-FY27 commissioning, a 700-bed Lucknow Shaheed Path greenfield has been board-approved at INR 1,400 crore, a 450-bed super-specialty hospital is planned in Pune, and the acquired 250-bed Kalinga Hospital Bhubaneswar marks entry into Eastern India.
Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from MAX HEALTHCARE INS LTD's filed financials and exchange disclosures
MAX HEALTHCARE INS LTD is a Healthcare Services company listed on NSE and BSE, trading under the symbol MAXHEALTH.
Yes. Over the trailing twelve months MAX HEALTHCARE INS LTD reported a net profit of ₹1,457 Cr on revenue of ₹8,712 Cr.
Yes. The dividend yield is 0.14% at the current price. It paid out 10% of its profit as dividend in FY26.
No. Debt stands at 0.32× equity, and it carries net debt of ₹2,813 Cr. That is lower than 30% of its 24 Hospital peers.
On trailing P/E, MAX HEALTHCARE INS LTD ranks 24 of 30 in Hospital — cheaper than 21% of them, against an industry median of 47.3×. This is a position, not a valuation judgement.
On a typical session MAX HEALTHCARE INS LTD moves 0.94% — that is the median absolute close-to-close move across its last 269 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by MAX HEALTHCARE INS LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.